Company Filing History:
Years Active: 2011
Title: Genc Basha: Innovator in Vaccine Development
Introduction
Genc Basha is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of immunology, particularly in the development of vaccine compositions aimed at combating viral infections. His innovative work has the potential to enhance the effectiveness of vaccines, especially in the treatment of serious diseases.
Latest Patents
Genc Basha holds 1 patent for a vaccine composition designed to combat viral infections in living organisms, including humans. This patent involves the use of TAP-1 and/or TAP-2 to augment the antigen processing capability of infected cells, thereby enhancing their immunogenicity. The composition can be utilized alone or as an immunogenicity-enhancing adjuvant with a pox antigen-based vaccine, particularly for the treatment or prevention of viral infections such as smallpox.
Career Highlights
Genc Basha is currently associated with Tapimmune Inc., a company focused on advancing immunotherapy and vaccine development. His work at Tapimmune has positioned him as a key player in the ongoing fight against viral diseases. His innovative approach to vaccine formulation reflects his commitment to improving public health outcomes.
Collaborations
Genc Basha collaborates with esteemed colleagues, including Wilfred A Jefferies and Timothy Z Vitalis. These partnerships enhance the research and development efforts at Tapimmune Inc., fostering an environment of innovation and scientific advancement.
Conclusion
Genc Basha's contributions to vaccine development exemplify the impact of innovative thinking in the field of immunology. His work not only advances scientific knowledge but also holds promise for improving health outcomes in the fight against viral infections.